, China

ZhongAn Online premiums hit $1.68b in 2018

The company is China’s first online-only insurer to break the $1.49b premium mark.

Insurtech firm ZhongAn Online saw its gross written premiums (GWP) surge 89% YoY to $1.68b (RMB11.3b) in 2018 to mark the first time that a web-only Chinese insurance firm broke the $1.49b (RMB10b) premium mark. 

The firm’s headline figures pushes it up to 12th place in the country’s property and casualty sector, up six notches from a year earlier. ZhongAn Online’s market share of the online non-auto P&C insurance also hit 31%, making it the top player in online non-auto P&C insurance category in China.

Also read: China to eclipse US as world's largest insurance market by 2030s

Premium revenue from health, consumer finance and auto ecosystems rose 225.3% YoY to $1.12b (RMB7.5b) and accounting for 66% of total GWP.

GWP from the consumer finance ecosystem rose 240.5% YoY to $521.68m (RMB3.5b) whilst premiums from the auto ecosystem rose from $11.76m (RMB78.9m) to $163.96m (RMB1.1b).

As of 31 December 2018, ZhongAn claims to have provided services for over 400 million users, with premium contribution per capita at approximately $4.17 (RMB28.0), representing a year-on-year increase of 103%. The number of insurance policies per capita also rose 25% to 15.8.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.